Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Karen Desouza"'
Autor:
Salma El Badri, Bilal Tahir, Kirsty Balachandran, Pavel Bezecny, Fiona Britton, Mark Davies, Karen Desouza, Simon Dixon, Daniel Hills, Maung Moe, Thomas Pigott, Andrew Proctor, Yatri Shah, Richard Simcock, Anna Stansfeld, Alicja Synowiec, Marianna Theodoulou, Mark Verrill, Anshu Wadhawan, Catherine Harper-Wynne, Caroline Wilson
Publikováno v:
Breast, Vol 60, Iss , Pp 199-205 (2021)
Background: Breast cancer incidence increases with age and real-world data is essential to guide prescribing practices in the older population. The aim of this study was to collect large scale real-world data on tolerability and efficacy of palbocicl
Externí odkaz:
https://doaj.org/article/e5841970e817475a94c42a86013872c9
Autor:
Richard Simcock, Yatri Shah, Thomas Pigott, Maung Maung Myat Moe, Simon Dixon, Alicja Synowiec, Pavel Bezecny, Bilal A Tahir, Kirsty Balachandran, Salma El Badri, Catherine Harper-Wynne, Marianna Theodoulou, Fiona Britton, Anna Stansfeld, Karen Desouza, Andrew Proctor, Anshu Wadhawan, M. Davies, Daniel Hills, Mark Verrill, Caroline Wilson
Publikováno v:
Breast, Vol 60, Iss, Pp 199-205 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Background Breast cancer incidence increases with age and real-world data is essential to guide prescribing practices in the older population. The aim of this study was to collect large scale real-world data on tolerability and efficacy of palbocicli
Autor:
Chara Stavraka, Janine Mansi, Karen DeSouza, Anthony M. Marinaki, E. Karapanagiotou, Matthaios Kapiris, Athanasios Pouptsis, Leroy Okonta, Dionysis Papadatos-Pastos, Philip Charlton
Publikováno v:
Breast Cancer Research and Treatment
Purpose Metastatic breast cancer (mBC) patients with DPYD genetic variants linked to loss of dihydropyrimidine dehydrogenase (DPD) activity are at risk of severe capecitabine-associated toxicities. However, prospective DPYD genotyping has not yet bee
Autor:
A. Proctor, M. Moe, K. Balachandran, Karen Desouza, Anna Stansfeld, F. Britton, Bilal A Tahir, Alicja Synowiec, Mark Verrill, Richard Simcock, Daniel Hills, Y. Shah, Pavel Bezecny, S. El Badri, M. Theodoulou, Caroline Wilson, T. Pigott, Anshu Wadhawan, Catherine Harper-Wynne
Publikováno v:
Annals of Oncology. 32:S466
Autor:
Srinivasan Madhusudan, Sumbal Umar, Maria Diossy, Karen Desouza, Anjana Anand, Emma Gore, Sachin Trivedi, Daniel Yeo, Sarah Khan
Publikováno v:
Journal of Clinical Oncology. 39:e13031-e13031
e13031 Background: The use of CDKIs have transformed the management of ER+HER2- mBC. As the real-world data matures, this project describes patterns in response to systemic therapy that may inform treatment planning and prognostication. Methods: We a
Autor:
Richard Simcock, Karen DeSouza, Anna Haire, Rosa-Rita Zammit, Janine Mansi, Elinor J. Sawyer, Gargi Patel, Rajesh Sinha, Anca Mera, E. Karapanagiotou, Charlotte Hannah Moss
Publikováno v:
Journal of Clinical Oncology. 37:e12503-e12503
e12503 Background: The oncological management of HER2+ mBC is complicated by the development of resistance to HER2-directed therapies (HER2-DTs). This project analyses real-world clinical data to determine disease response patterns that may guide tre
Autor:
Constantinos Savva, Karen DeSouza
Publikováno v:
Journal of Cancer Prevention & Current Research. 6
Background: Over the last 5 years ever since Ipilimumab received FDA approval for the treatment of metastatic melanoma, immunotherapy as a treatment modality is making its presence felt in oncology clinics across the globe. While initially approved f
Autor:
Sumaira Rafiqui, Merlin Thomas, Muna Almaslamani, Karen Desouza, Abdel-Naser Elzo, Saibu George
Publikováno v:
Journal of Emergency Medicine, Trauma and Acute Care. 2016
Background/objective: Several inflammatory biomarkers of infection including procalcitonin (PCT) and C – reactive protein (CRP) have been shown to be useful in diagnosis of infection in different clinical settings. The purpose of this study was to
Publikováno v:
The Practitioner. 258(1767)
Bladder cancer is the most frequently diagnosed cancer involving the urinary tract and is the seventh most common cancer in the UK. Delayed diagnosis is associated with high-grade muscle invasive disease which has the potential to progress rapidly, m